Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.83%204.571.3%$443.37m
BIIBBiogen Inc.
0.31%226.471.3%$383.48m
GILDGilead Sciences, Inc.
1.61%65.550.9%$368.10m
CELGCelgene Corporation
0.74%101.141.3%$355.01m
ILMNIllumina, Inc.
0.35%311.413.5%$267.64m
REGNRegeneron Pharmaceuticals, Inc.
-0.05%305.292.6%$219.64m
EXASExact Sciences Corporation
4.88%99.4824.1%$209.12m
ALXNAlexion Pharmaceuticals, Inc.
3.29%104.682.0%$187.03m
VRTXVertex Pharmaceuticals Incorporated
1.69%176.531.9%$181.86m
AAgilent Technologies, Inc.
1.01%75.941.6%$155.32m
SRPTSarepta Therapeutics, Inc.
1.46%86.9514.6%$143.78m
ALDRAlder Biopharmaceuticals, Inc.
-0.11%18.9010.2%$132.19m
BMRNBioMarin Pharmaceutical Inc.
2.14%68.684.3%$98.00m
ACADACADIA Pharmaceuticals Inc.
1.82%40.2013.4%$91.21m
NKTRNektar Therapeutics
9.55%17.395.5%$86.25m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.